Early test of 3-Month vaginal ring to block HIV
NCT ID NCT03670355
Summary
This early-stage study tested a vaginal ring designed to be worn for 90 days to prevent HIV infection. It aimed to see if the ring safely delivered a preventive drug called tenofovir to the right areas of the body. The study involved 49 healthy, HIV-negative women who were randomly assigned to receive either the active ring or a placebo ring for about three months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alabama CRS
Birmingham, Alabama, 35294, United States
-
Bridge HIV CRS
San Francisco, California, 94143, United States
-
University of Pittsburgh CRS
Pittsburgh, Pennsylvania, 15213, United States
Conditions
Explore the condition pages connected to this study.